Email Newsletters

UMass Medical School

UMass Medical School renews $30M NIH award

UMass Medical School has renewed a five-year, $30-million clinical and translational sciences award from the National Institutes of Health.

MassBiologics researchers cite potential coronavirus vaccine

Researchers at MassBiologics, an arm of Worcester's UMass Medical School, have published a study suggesting antibodies may provide immunity in the respiratory system against coronavirus.

UMass Medical School executive to depart

UMass Medical School's executive vice chancellor for innovation and business development will depart the Worcester college next year.

UMass Medical School announces ALS breakthrough

Researchers at UMass Medical School and Massachusetts General Hospital have announced a major breakthrough in ALS research: a therapy that suppresses a harmful gene that causes the nervous system disease.
- Advertisement -

UMass Medical School tuition up 1.5 percent

UMass officials advanced a 1.5 percent tuition hike for medical school students, and shined a bit more light on what students across the other campuses might expect to pay next year.

AP: UMass Nobelist learned of gene-edited babies last April

A UMass Medical School professor and Nobel Prize winner knew of a Chinese researcher's work on gene-edited babies before that work became public, according to the Associated Press.

Swiss firm licenses gene therapies from UMass Medical School

A Swiss company developing gene therapies for neurological diseases has licensed programs researched at UMass Medical School in Worcester

UMass Medical School researchers find potential therapy for preeclampsia

Two researchers at UMass Medical School and collaborating researchers have found a new type of therapy they believe can alleviate the symptoms of preeclampsia.
- Advertisement -

UMMS gets $1.4M to push genetic disorder treatment to human trials

A Toronto foundation has donated $1.4 million to UMass Medical School in Worcester to advance a gene therapy to treat genetic disorder Tay-Sachs.

UMass research nearing clinical trials for ALS therapy

Researchers at UMass Medical School in Worcester think a new kind of gene therapy may safely treat patients with ALS.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Black Friday Sale! Get 40% off new subscriptions through Sunday, 11/30!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA